The Top 60: Blue Diesel

Blue Diesel president Kelly Gratz doesn't come right out and say that her firm thrived during a time when many others struggled. But then, she doesn't have to, as the interactive specialist's spate of new business and personnel growth—Gratz estimates that headcount “about tripled” from where it was at this time last year—speak for themselves.

Blue Diesel grew its longstanding relationship with Merck, adding work for Cordaptive, hepatitis vaccine Vaqta and in-the-pipeline obesity therapy Taranabant. 

While entities as diverse as Ethicon and the Healthy Advice Network hired Blue Diesel to bolster their web presences, the company's biggest win in recent months was probably Ortho-McNeil-Janssen Pharmaceuticals' ADHD treatment Concerta. She says that Blue Diesel didn't shed any accounts during the past year.

Over the last 12 months, Blue Diesel overhauled its structure into what Gratz calls “a studio model—instead of four inches across and an inch deep, we're now two across and five deep.” The company also expanded, opening up its doors in Newtown, PA.

“Interactive may become a different kind of ballgame,” Gratz says. “Everything we did last year and so far this year has been designed to keep us ahead of the curve.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.